GENE ONLINE|News &
Opinion
Blog

Special
History on Depression Therapy: the Past and the Psychedelic Future
2022-03-21
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
BIO CEO 2022: Trends and Opportunities in Biotechnology Investments
2022-02-26
The Golden Age of Genomics Sequencing
2022-02-20Partner
Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials
2022-02-14
GeneOnline’s Pick: Novel Biotechnologies that Made a Splash in 2021
2022-01-27
Biotech Showcase 2022: The China Factor
2022-01-24
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
Biotech Showcase 2022: Healing the Psyche with Psychedelia
2022-01-17
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
JPM22 Highlights: Cell and Gene Therapies Rise Up
2022-01-11
As Regenerative Medicine Grows in Japan, Challenges Remain
2021-12-24
ASH 2021: Engineering Stem Cells into Therapeutic Immune Cells
2021-12-21
1 11 12 13 14 15 20
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top